U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

THIS PAGE IS TEMPORARILY UNDER CONSTRUCTION WHILE ENHANCEMENTS ARE UNDERWAY. Drug shortage data continues to be updated while under construction.

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Somatropin Injection
Status: Currently in Shortage
»Date first posted: 01/06/2023
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Eli Lilly and Co. (Reverified 02/05/2024)

Company Contact Information:
800-545-5979

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Humatrope, Injection, 12 mg/vial (NDC 0002-8148-01) Available
Humatrope, Injection, 24 mg/vial (NDC 0002-8149-01) Available

Genentech, Inc (Revised 01/23/2024)

Company Contact Information:
800-551-2231

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Nutropin Aq, Injection, 10 mg/2 mL (NDC 50242-074-01) Limited Supply, expected supply stability mid-2024 Demand increase for the drug
Nutropin Aq, Injection, 5 mg/2 mL (NDC 50242-075-01) Limited Supply, expected supply stability mid-2024 Demand increase for the drug
Nutropin Aq, Injection, 20 mg/2 mL (NDC 50242-076-01) Limited Supply, expected supply stability mid-2024 Demand increase for the drug

Novo Nordisk, Inc. (Reverified 02/05/2024)

Company Contact Information:
609-987-5800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Norditropin, Injection, 5 mg/1.5 mL (NDC 0169-7704-21) Intermittent supply until end of Q1 2024 Delay in shipping of the drug
Norditropin, Injection, 10 mg/1.5 mL (NDC 0169-7705-21) Intermittent supply until end of Q1 2024 Delay in shipping of the drug
Norditropin, Injection, 15 mg/1.5 mL (NDC 0169-7708-21) Intermittent supply until end of Q1 2024 Delay in shipping of the drug
Norditropin, Injection, 30 mg/3 mL (NDC 0169-7703-21) Intermittent supply until end of Q1 2024 Delay in shipping of the drug

Pfizer Inc. (Reverified 02/09/2024)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Genotropin, Injection, 5 mg/mL (NDC 0013-2626-81) Available Demand increase for the drug
Genotropin, Injection, 12 mg/vial (NDC 0013-2646-81) Available Demand increase for the drug
Genotropin, Injection, 0.2 mg/vial (NDC 0013-2649-02) Limited Supply Available. Next Delivery: April 2024; Estimated Recovery: Q3 2024 Demand increase for the drug
Genotropin, Injection, 0.4 mg/vial (NDC 0013-2650-02) Next Delivery: April 2024; Estimated Recovery: Q3 2024 Demand increase for the drug
Genotropin, Injection, 0.6 mg/vial (NDC 0013-2651-02) Next Delivery: February 2024; Estimated Recovery: Q3 2024 Demand increase for the drug
Genotropin, Injection, 0.8 mg/vial (NDC 0013-2652-02) Next Delivery: February 2024; Estimated Recovery: Q3 2024 Demand increase for the drug
Genotropin, Injection, 1.0 mg/vial (NDC 0013-2653-02) Next Delivery: April 2024; Estimated Recovery: Q3 2024 Demand increase for the drug
Genotropin, Injection, 1.2 mg/vial (NDC 0013-2654-02) Next Delivery: March 2024; Estimated Recovery: Q3 2024 Demand increase for the drug
Genotropin, Injection, 1.4 mg/vial (NDC 0013-2655-02) Next Delivery: February 2024; Estimated Recvoery: Q3 2024 Demand increase for the drug
Genotropin, Injection, 1.6 mg/vial (NDC 0013-2656-02) Next Delivery: February 2024; Estimated Recvoery: Q3 2024 Demand increase for the drug
Genotropin, Injection, 1.8 mg/vial (NDC 0013-2657-02) Next Delivery: April 2024; Estimated Recovery: Q3 2024 Demand increase for the drug
Genotropin, Injection, 2.0 mg/vial (NDC 0013-2658-02) Next Delivery: February 2024; Estimated Recovery: Q3 2024 Demand increase for the drug

Sandoz Inc. (Reverified 02/06/2024)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Omnitrope, Injection, 5 mg/1.5 mL (NDC 0781-3001-07) Available
Omnitrope, Injection, 10 mg/1.5 mL (NDC 0781-3004-07) Available
Back to Top